Skip to Main Content

Paper Details

An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike.
Science
270
2020
ACE2, Nb6, SARS, SARS-CoV, SARS-CoV-2, Spike, Spike protein, angiotensin, angiotensin-converting enzyme 2, host cell receptor, host cells, mNb6-tri, severe, severe acute respiratory syndrome coronavirus 2, synthetic nanobody sequences, yeast
Angiotensin-Converting Enzyme 2, Animals, Antibodies, Neutralizing, Antibodies, Viral, Antibody Affinity, Chlorocebus aethiops, Cryoelectron Microscopy, Humans, Neutralization Tests, Protein Binding, Protein Stability, Single-Domain Antibodies, Spike Glycoprotein, Coronavirus, Vero Cells
Author NameAffiliation
Michael SchoofHoward Hughes Medical Institute, University of California at San Francisco
Michael SchoofUniversity of California at San Francisco
Bryan FaustHoward Hughes Medical Institute, University of California at San Francisco
Bryan FaustUniversity of California at San Francisco
Bryan FaustDepartment of Pharmaceutical Chemistry, University of California at San Francisco
Bryan FaustQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Reuben A SaundersHoward Hughes Medical Institute, University of California at San Francisco
Reuben A SaundersUniversity of California at San Francisco
Smriti SangwanHoward Hughes Medical Institute, University of California at San Francisco
Smriti SangwanUniversity of California at San Francisco
Veronica V RezeljCNRS UMR 3569, Institut Pasteur
Nick HoppeDepartment of Pharmaceutical Chemistry, University of California at San Francisco
Nick HoppeQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Morgane BooneHoward Hughes Medical Institute, University of California at San Francisco
Morgane BooneUniversity of California at San Francisco
Christian B Billesb??lleDepartment of Pharmaceutical Chemistry, University of California at San Francisco
Christian B Billesb??lleQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Cristina PuchadesQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Caleigh M AzumayaQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Huong T KratochvilQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Marcell ZimanyiHoward Hughes Medical Institute, University of California at San Francisco
Marcell ZimanyiUniversity of California at San Francisco
Ishan DeshpandeDepartment of Pharmaceutical Chemistry, University of California at San Francisco
Ishan DeshpandeQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Jiahao LiangDepartment of Pharmaceutical Chemistry, University of California at San Francisco
Sasha DickinsonQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Henry C NguyenQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Cynthia M ChioQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Gregory E MerzQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Michael C ThompsonQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Devan DiwanjiQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Kaitlin SchaeferQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Aditya A AnandHoward Hughes Medical Institute, University of California at San Francisco
Aditya A AnandUniversity of California at San Francisco
Niv DobzinskiHoward Hughes Medical Institute, University of California at San Francisco
Niv DobzinskiUniversity of California at San Francisco
Beth S ZhaUniversity of California San Francisco
Camille R SimoneauQuantitative Biosciences Institute (QBI), University of California San Francisco
Camille R SimoneauJ. David Gladstone Institutes
Camille R SimoneauUniversity of California San Francisco
Kristoffer E LeonQuantitative Biosciences Institute (QBI), University of California San Francisco
Kristoffer E LeonJ. David Gladstone Institutes
Kristoffer E LeonUniversity of California San Francisco
Kris M WhiteIcahn School of Medicine at Mount Sinai
Kris M WhiteGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai
Un Seng ChioQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Meghna GuptaQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Mingliang JinQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Fei LiQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
Yanxin LiuQuantitative Biosciences Institute (QBI) Coronavirus Research Group Structural Biology Consortium, University of California san francisco
  • 1 - 50

Datasets